2019-08 FDA approves Pretomanid Tablets in combination with bedaquiline and linezolid for treatment of XDR-TB
Extensively drug-resistant tuberculosis (XDR-TB)LinezolidPretomanidUnited States Food and Drug Administration (FDA)
2020-03 Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Extensively drug-resistant tuberculosis (XDR-TB)
LAM4/KZN
Extensively drug-resistant tuberculosis (XDR-TB)
A bad patchhttps://www.thehindu.com/opinion/open-page/a-bad-patch/article31069356.ece
Extensively drug-resistant tuberculosis (XDR-TB)
Clinical Use of the Meropenem-Clavulanate Combination for Extensively Drug-Resistant Tuberculosis - PubMedhttps://pubmed.ncbi.nlm.nih.gov/22325421/
Extensively drug-resistant tuberculosis (XDR-TB)Meropenem-clavulanate
Mumbai pharma company gets licence for breakthrough TB drug | India News - Times of Indiahttps://timesofindia.indiatimes.com/india/mumbai-pharma-company-gets-licence-for-breakthrough-tb-drug/articleshow/71787870.cms
Bedaquiline-linezolid-pretomanid (BPaL)Extensively drug-resistant tuberculosis (XDR-TB)PretomanidTB Alliance
Stewardship / Resistance Scan for Dec 16, 2019 | CIDRAPhttp://www.cidrap.umn.edu/news-perspective/2019/12/stewardship-resistance-scan-dec-16-2019
Extensively drug-resistant tuberculosis (XDR-TB)
The End Tuberculosis Now Act of 2019 - BORGENhttps://www.borgenmagazine.com/the-end-tuberculosis-now-act-of-2019/
Extensively drug-resistant tuberculosis (XDR-TB)

Showing topic

Extensively drug-resistant tuberculosis (XDR-TB)
Extensively drug-resistant (XDR) bacteriaFluoroquinolonesMultidrug-resistant tuberculosis (MDR-TB)